Functional magnetic resonance imaging of phonologic processing in neurofibromatosis 1

Journal of Child Neurology

Volumn 18, Issue 11, 2003, Pages 731-740

  Billingsley, Rebecca L ^a   Jackson, Edward F ^a   Slopis, John M ^a   Swank, Paul R ^a   Mahankali, Srikanth ^a   Moore III, Barlett D ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; CASE CONTROL STUDY; CHILD; CHILD BEHAVIOR; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSLEXIA; FEMALE; HEARING; HUMAN; LANGUAGE DEVELOPMENT; MALE; NEUROANATOMY; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; PARIETAL LOBE; PATHOLOGY; PATHOPHYSIOLOGY; PHONETICS; PHYSIOLOGY; PREFRONTAL CORTEX; PRIORITY JOURNAL; READING; SCHOOL CHILD; SIGNAL PROCESSING; TASK PERFORMANCE; TEMPORAL LOBE; VISION;

EID: 0347513296     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738030180110701     Document Type: Article

References (45)

1. Bale SJ, Amos CI, Parry DM, Bale AE: Relationship between head circumference and height in normal adults and in the nevoid basal cell carcinoma syndrome and neurofibromatosis type I. Am J Med Genet 1991;40:206-210.
2. Listernick R, Charrow J, Greenwald MJ, Easterly NB: Optic gliomas in children with neurofibromatosis type 1. J Pediatr Psychol 1989;114:788-792.
3. Eliason MJ: Neurofibromatosis: Implications for behavior and learning. Neurofibromatosis 1986;7:175-179.
4. Varnhagen CK, Lewin S, Das JP, et al: Neurofibromatosis and psychological processes. J Dev Behav Pediatr 1988;9:257-265.
5. Hofman KJ, Harris EL, Bryan RN, Denckla MB: Neurofibromatosis type 1: The cognitive phenotype. J Pediatr 1994;124 (Suppl):S1-S8.
6. Mazzocco MM, Turner JE, Denckla MB, et al: Language and reading deficits associated with neurofibromatosis type 1: Evidence for a not-so-nonverbal learning disability. Dev Neuropsychol 1995;11:503-522.
7. Cutting LE, Koth CW, Denckla MB: How children with neurofibromatosis type 1 differ from "typical" learning disabled clinic attenders: Nonverbal learning disabilities revisited. Dev Neuropsychol 2000;17:29-47.
8. 2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1. Am J Med Genet 1996;67:98-102.
9. Duffner P, Cohen M, Seidel F, Shucard D: The significance of MRI abnormalities in children with neurofibromatosis. Neurology 1989;39:373-378.
10. 2 weighted lesions and their relationship to intellectual impairment. J Neurol Neurosurg Psychiatry 1993;56:492-495.
11. Moore BD, Slopis JM, Jackson EF, et al: Brain volume in children with neurofibromatosis, type 1: Relation to neuropsychological status. Neurology 2000;54:914-920.
12. Moore BD, Slopis JM, Schomer D, et al: Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis. Neurology 1996;46:1660-1668.
13. North K, Joy P, Yuille D, et al: Specific learning disability in children with neurofibromatosis type 1: Significance of MRI abnormalities. Neurology 1994;44:878-883.
14. 2-weighted hyperintensities in neurofibromatosis-1. J Child Neurol 2000;15:157-160.
15. Kayle AE, Moore BD, Slopis JM, et al: Quantitative morphology of the corpus callosum in children with neurofibromatosis and attention-deficit hyperactivity disorder. J Child Neurol 2000;15:90-96.
16. Billingsley RL, Schrimsher GW, Jackson EF, et al: Significance of planum temporale and planum parietale morphologic features in neurofibromatosis, type I. Arch Neurol 2002;59:616-622.
17. Billingsley RL, Slopis JM, Swank PR, et al: Cortical morphology associated with language function in neurofibromatosis, type I. Brain Lang 2003;85:125-139.
18. Billingsley RL, McAndrews MP, Crawley A, Mikulis D: Functional MRI analyses of phonological and semantic processing in temporal lobe epilepsy. Brain 2001;124:1218-1227.
19. Eden GF, VanMeter JW, Rumsey JM, et al: Abnormal processing of visual motion in dyslexia revealed by functional brain imaging. Nature 1996;382:66-69.
20. Paulesu E, Frith U, Snowling M, et al: Is developmental dyslexia a disconnection syndrome? Evidence from PET scanning. Brain 1996;119:143-157.
21. Shaywitz SE, Shaywitz BA, Pugh KR, et al: Functional disruption in the organization of the brain for reading in dyslexia. Proc Natl Acad Sci U S A 1998;95:2636-2641.
22. Temple E, Poldrack RA, Salidis J, et al: Disrupted neural responses to phonological and orthographic processing in dyslexic children: An fMRI study. Neuroreport 2001;12:299-307.
23. Stanovich KE: Explaining the differences between the dyslexic and the garden-variety poor reader: The phonological-core variable-difference model. J Learn Disabil 1988;21:590-604.
24. Fletcher JM, Shaywitz SE, Shankweiler DP, et al: Cognitive profiles of reading disability: Comparisons of discrepancy and low achievement definitions. J Educ Psychol 1994;86:6-23.
25. Pugh KR, Shaywitz BA, Shaywitz SE, et al: Cerebral organization of component processes in reading. Brain 1996;119:1221-1238.
26. Simos PG, Fletcher JM, Bergman E, et al: Dyslexia-specific brain activation profile becomes normal following successful remedial training. Neurology 2002;58:1203-1213.
27. Temple E: Brain mechanisms in normal and dyslexic readers. Curr Opin Neurobiol 2002;12:178-183.
28. Schrimsher GW, Billingsley RL, Slopis JM, Moore BD: Visual-spatial performance deficits in children with neurofibromatosis type-1. Am J Med Genet 2003;120A(3):326-330.
29. National Institutes of Health: National Institutes of Health consensus development conference. Neurofibromatosis conference statement. Arch Neurol 1988;45:575-578.
30. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC, American Psychiatric Association, 1994.
31. Rao SM, Salmeron BJ, Durgerian S, et al: Effects of methylphenidate on functional MRI blood-oxygen-level-dependent contrast. Am J Psychiatry 2000;157:1697-1699.
32. Vaidya CJ, Austin G, Kirkorian G, et al: Selective effects of methylphenidate in attention deficit hyperactivity disorder: A functional magnetic resonance study. Proc Natl Acad Sci U S A 1998;95:14494-14499.
33. Cox RW: AFNI: Software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 1996;29:162-173.
34. Bandettini PA, Jesmanowicz A, Wong EC, Hyde JS: Processing strategies for time-course data sets in functional MRI of the human brain. Magn Reson Med 1993;30:161-173.
35. Talairach J, Tournoux P: Co-planar Stereotaxic Atlas of the Human Brain. New York, Thieme Medical Publishers, 1988.
36. Woodcock RW, Johnson MB: Woodcock Johnson Psycho-Educational Battery-Revised. Allen, TX, DLM Teaching Resources, 1989.
37. Wilkinson GS: The Wide Range Achievement Test Administration Manual. Wilmington, DE, Wide Range, Inc., 1993.
38. Wechsler D: Wechsler Intelligence Scale for Children, 3rd ed. New York, Harcourt, Brace, Jovanovich, 1991.
39. Binder JR, Frost JA, Hammeke TA, et al: Function of the left planum temporale in auditory and linguistic processing. Brain 1996;119:1239-1247.
40. Demonet J-F, Chollet F, Ramsay S, et al: The anatomy of phonological and semantic processing in normal subjects. Brain 1992;115:1753-1768.
41. Rumsey JM, Horwitz B, Donohue BC, et al: Phonological and orthographic components of word recognition. Brain 1997;120:739-759.
42. Zatorre RJ, Evans AC, Meyer E, Gjedde A: Lateralization of phonetic and pitch discrimination in speech processing. Science 1992;256:846-849.
43. Klingberg T, Hedehus M, Temple E, et al: Microstructure of temporoparietal white matter as a basis for reading ability: Evidence from diffusion tensor magnetic resonance imaging. Neuron 2000;25:493-500.
44. Rubia K: The dynamic approach to neurodevelopmental psychiatric disorders: Use of fMRI combined with neuropsychology to elucidate the dynamics of psychiatric disorders, exemplified in ADHD and schizophrenia. Behav Brain Res 2002;130:47-56.
45. Baumeister AA, Hawkins MF: Incoherence of neuroimaging studies of attention deficit/hyperactivity disorder. Clin Neuropharmacol 2001;24:2-10.